161 related articles for article (PubMed ID: 28070935)
1. Alendronate-anchored PEGylation of ceria nanoparticles promotes human hepatoma cell proliferation via AKT/ERK signaling pathways.
Cheng H; Liao ZL; Ning LH; Chen HY; Wei SS; Yang XC; Guo H
Cancer Med; 2017 Feb; 6(2):374-381. PubMed ID: 28070935
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, physico-chemical characterization, and antioxidant effect of PEGylated cerium oxide nanoparticles.
Xue Y; Balmuri SR; Patel A; Sant V; Sant S
Drug Deliv Transl Res; 2018 Apr; 8(2):357-367. PubMed ID: 28589454
[TBL] [Abstract][Full Text] [Related]
3. Nano-Cerium Oxide Promotes Proliferation of Hepatoma Cells and Regulates mRNA Expression of Apoptosis-Related Genes Bcl-2 and Bax, as Detected Through Real-Time Fluorescent Quantitative Polymerase Chain Reaction.
Liu Z; Wang X; Xing Z; Xu P; Sun J
J Nanosci Nanotechnol; 2020 Dec; 20(12):7457-7463. PubMed ID: 32711615
[TBL] [Abstract][Full Text] [Related]
4. PEGylated ceria nanoparticles used for radioprotection on human liver cells under γ-ray irradiation.
Li H; Yang ZY; Liu C; Zeng YP; Hao YH; Gu Y; Wang WD; Li R
Free Radic Biol Med; 2015 Oct; 87():26-35. PubMed ID: 26117316
[TBL] [Abstract][Full Text] [Related]
5. Ceria nanoparticles enhance endochondral ossification-based critical-sized bone defect regeneration by promoting the hypertrophic differentiation of BMSCs
Li J; Kang F; Gong X; Bai Y; Dai J; Zhao C; Dou C; Cao Z; Liang M; Dong R; Jiang H; Yang X; Dong S
FASEB J; 2019 May; 33(5):6378-6389. PubMed ID: 30776318
[TBL] [Abstract][Full Text] [Related]
6. Cerium oxide nanoparticles inhibit the migration and proliferation of gastric cancer by increasing DHX15 expression.
Xiao YF; Li JM; Wang SM; Yong X; Tang B; Jie MM; Dong H; Yang XC; Yang SM
Int J Nanomedicine; 2016; 11():3023-34. PubMed ID: 27486320
[TBL] [Abstract][Full Text] [Related]
7. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
Wang J; Luo Z; Yao T; Li W; Pu J
J Cell Physiol; 2019 May; 234(5):6908-6916. PubMed ID: 30317590
[TBL] [Abstract][Full Text] [Related]
8. Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Aβ aggregates modulate neuronal survival pathways.
Cimini A; D'Angelo B; Das S; Gentile R; Benedetti E; Singh V; Monaco AM; Santucci S; Seal S
Acta Biomater; 2012 Jul; 8(6):2056-67. PubMed ID: 22343002
[TBL] [Abstract][Full Text] [Related]
9. NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells.
Liu L; Chen J; Cao M; Wang J; Wang S
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1303-1314. PubMed ID: 31555866
[TBL] [Abstract][Full Text] [Related]
10. Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency.
Na JH; Lee SY; Lee S; Koo H; Min KH; Jeong SY; Yuk SH; Kim K; Kwon IC
J Control Release; 2012 Oct; 163(1):2-9. PubMed ID: 22846988
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of tumor growth and invasion by redox-active nanoparticles.
Alili L; Sack M; von Montfort C; Giri S; Das S; Carroll KS; Zanger K; Seal S; Brenneisen P
Antioxid Redox Signal; 2013 Sep; 19(8):765-78. PubMed ID: 23198807
[TBL] [Abstract][Full Text] [Related]
12. Anlotinib induces hepatocellular carcinoma apoptosis and inhibits proliferation via Erk and Akt pathway.
He C; Wu T; Hao Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):3093-3099. PubMed ID: 30146257
[TBL] [Abstract][Full Text] [Related]
13. PEGylated nanoceria as radical scavenger with tunable redox chemistry.
Karakoti AS; Singh S; Kumar A; Malinska M; Kuchibhatla SV; Wozniak K; Self WT; Seal S
J Am Chem Soc; 2009 Oct; 131(40):14144-5. PubMed ID: 19769392
[TBL] [Abstract][Full Text] [Related]
14. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
[TBL] [Abstract][Full Text] [Related]
15. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
Wu L; Zheng J; Chen P; Liu Q; Yuan Y
Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
[TBL] [Abstract][Full Text] [Related]
16. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase pathway is pivotal for anoikis resistance in metastatic hepatoma cells.
Cao L; Zhang Z; Han L; Du J; Liang X; Liu Y; Sun W
Mol Med Rep; 2014 Apr; 9(4):1121-7. PubMed ID: 24535322
[TBL] [Abstract][Full Text] [Related]
18. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
Wang JG; Zheng XX; Zeng GY; Zhou YJ; Yuan H
Oncol Rep; 2014 Jan; 31(1):488-96. PubMed ID: 24247909
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Akt/NF-κB-regulated inflammation and Akt/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle.
Tang B; Tang F; Wang Z; Qi G; Liang X; Li B; Yuan S; Liu J; Yu S; He S
Int J Nanomedicine; 2016; 11():6401-6420. PubMed ID: 27942213
[TBL] [Abstract][Full Text] [Related]
20. Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns.
Cai J; Zhao XL; Liu AW; Nian H; Zhang SH
Phytomedicine; 2011 Mar; 18(5):366-73. PubMed ID: 20850954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
